News
-
Vista Pharma awaits USFDA nod for launch of gDofetilide; stock surges 4.5%
14:22 IST, Jan 04The company has completed all data filings and GDUFA fee payments for 2019 and is waiting for approval from USFDA for the commercial la
-
Vista Pharmaceuticals hits 10% upper circuit
12:59 IST, May 29The company already filed a complex ANDA in September 2017, targeting Cardiology segment with a market size of $200 million (Rs1,360cr)
-
Vista Pharma submits ANDA to USFDA for cardiac drug
14:25 IST, Sep 26Vista Pharmaceuticals informed that the company has submitted an Abbreviated New Drug Application (ANDA) to USFDA on September 25, 2017
-
Vista Pharmaceuticals gains after receipt of EIR report
11:29 IST, Sep 08Vista Pharmaceuticals edged higher on bourses during Fridays trade on the back of the EIR report issued by USFDA on Thursday.
